Menta Capital’s Pfizer PFE Stock Holding History

Menta Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,278	Closed	-$380K	–	735
2018 Q1	$380K	Buy	+11,278	New	+$388K	0.08%	408
2017 Q2	–	Sell	-12,255	Closed	-$398K	–	887
2017 Q1	$398K	Sell	12,255 -147,232	-92%	-$4.64M	0.04%	624
2016 Q4	$4.92M	Buy	159,487 +22,345	+16%	+$682K	0.41%	26
2016 Q3	$4.41M	Buy	+137,142	New	+$4.59M	0.42%	15

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Menta Capital's PFE Position: Q2 2018 in Review

Menta Capital sold out of Pfizer (PFE) in Q2 2018, closing a stake of 11,278 shares — an estimated $380K sold.

Menta Capital first reported a position in PFE in Q3 2016 and held it in 4 quarters. The position peaked at $4.92M in Q4 2016. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Menta Capital reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Menta Capital sold 11,278 Pfizer shares in Q2 2018, an estimated $380K.
Menta Capital first reported a position in Pfizer in Q3 2016 and held it in 4 quarters.
Menta Capital's Pfizer position peaked at $4.92M in Q4 2016.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Menta Capital's 13F filing for Q2 2018, filed 14 Aug 2018.